Ellsworth Advisors, LLC

Position in NVS — Novartis AG

CIK 1843553 HUDSON, OH

Position in NVS

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$265,640

+$6,729 QoQ

Shares Held

1,695

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#1,194

of 1,603 holders

Holding Since

Jun 2025

5 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ellsworth Advisors, LLC holds $34,290,994 across 6 Drug Manufacturers - General names. NVS ranks #6 (0.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	49,045	$12,455,958
2	AMGN	Amgen Inc	22,329	$8,085,777
3	BMY	Bristol Myers Squibb Co	125,533	$7,233,211
4	LLY	ELI LILLY & Co	4,841	$5,806,441
5	MRK	Merck & Co., Inc.	3,455	$443,967
6	NVS	Novartis AG This page	1,695	$265,640

5 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$265,640	1,695	0.0%	Shares	Sole	2026-07-16
2026-03-31	$258,911	1,695	0.0%	Shares	Sole	2026-04-16
2025-12-31	$233,689	1,695	0.0%	Shares	Sole	2026-01-16
2025-09-30	$217,366	1,695	0.0%	Shares	Sole	2025-10-16
2025-06-30	$205,111	1,695	—	Shares	Sole	2025-07-23
No filing history on record for this holder in this stock.